Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

被引：0
|
作者：
Papageorgiou, Loula [1 ,2 ]
Fotiou, Despina [3 ]
Van Dreden, Patrick [4 ]
Garderet, Laurent [5 ,6 ]
Dimopoulos, Meletios A. [3 ,7 ]
Elalamy, Ismail [8 ]
Mohty, Mohamad [9 ,10 ,11 ]
Gerotziafas, Grigoris [12 ,13 ]
机构：
[1] Univ Pierre & Marie Curie UPMC, Paris Fac Med Pierre & Marie Curie, Inst Univ Cancerol IUC, Sorbonne Univ,Canc Biol & Therapeut,INSERM U938, Paris, France
[2] Tenon Univ Hosp, AP HP, Dept Haematol, Paris, France
[3] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[4] Stago, Clin Res, Gennevilliers, France
[5] Hop Pitie Salpetiere, AP HP, Serv Hematol, Paris, France
[6] Hop St Antoine, Ctr Rech St Antoine, Team Proliferat & Differentiat Stem Cells, Paris, France
[7] Univ Athens, Dept Clin Therapeut, Sch Med, Athens, Greece
[8] Paris 6 Univ, AP HP, Paris 20, France
[9] St Antoine Hosp, Dept Haematol, INSERM UMR 938, Paris, France
[10] St Antoine Hosp, EBMT Paris Study Off CEREST TC, INSERM UMR 938, Paris, France
[11] Univ Paris 06, Paris, France
[12] Sorbonne Univ, Inst Univ Cancerol, INSERM, Canc Haemostasis & Angiogenesis Res Grp, Paris, France
[13] Hop Tenon, AP HP, Thrombosis Ctr, Serv Hematol Biol, Paris, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126954
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1913
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Identifying microRNAs as potential biomarkers of drug resistance in multiple myeloma patients: proof-of-concept study
    Bergantim, Rui
    da Silva, Sara Peixoto
    Pereira, Joana
    Pinto, Vanessa
    Sousa, Diana
    Matthiesen, Rune
    Guimaraes, Jose Eduardo
    Helena Vasconcelos, M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S67 - S67
  • [12] Hybrid MEL/DT PACE autotransplant regimen for multiple myeloma (MM) - Safety and efficacy data in pilot study of 15 patients.
    Thertulien, R
    Barlogie, B
    Fassas, A
    Eddlemon, P
    Zangari, M
    Muwalla, F
    Morris, C
    Anaissie, E
    Fox, M
    Tricot, G
    BLOOD, 2001, 98 (11) : 686A - 686A
  • [13] A phase I-II clinical trial with a combination of gemcitabine (Gemzar) and paclitaxel (taxol) for the treatment of refractory multiple myeloma (MM) patients.
    Gazitt, Y
    Roodman, D
    Freytes, C
    Shaughnessy, P
    Callander, N
    Traynor, A
    Rothenberg, M
    BLOOD, 2000, 96 (11) : 287B - 287B
  • [14] Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly Diagnosed Chemotherapy Naive Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. The Observational ROADMAT-CAT-MM Study
    Fotiou, Despina
    Sergentanis, Theodoros
    Papageorgiou, Loula
    Gavriatopoulou, Maria
    Psaltopoulou, Theodora
    VanDreden, Patrick
    Larsen, Annette
    Elalamy, Ismail
    Kastritis, Efstathios
    Stamatelopoulos, Kimon
    Terpos, Evangelos
    Dimopoulos, Meletios
    Gerotziafas, Grigoris
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S235 - S236
  • [15] INSIGHT MM study of routine clinical practice in multiple myeloma: analysis of duration of therapy and treatment sequencing in UK patients
    Cook, G.
    Ashcroft, J.
    Boyd, K.
    Garg, M.
    Hall, R.
    Kishore, B.
    Moore, S.
    Smith, D.
    Crofts, N.
    Ren, K.
    Pratt, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 126 - 127
  • [16] Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study
    Pula, Anna
    Robak, Tadeusz
    Drozdz, Izabela
    Stawiski, Konrad
    Rycerz, Aleksander
    Misiewicz, Malgorzata
    Robak, Pawel
    LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 257 - 264
  • [17] A retrospective chart review study of relapsed or refractory multiple myeloma (MM) patients (Pts): A look into historical treatment (Tx) patterns
    Zaman, F.
    Reece, D. E.
    Teixeira, B. L.
    Yoong, K.
    Camacho, F.
    Plante, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [18] Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients: The Insight-MM Study
    Rifkin, Robert M.
    Davies, Faith E.
    Palumbo, Antonio
    Zonder, Jeffrey
    Girnius, Saulius K.
    Costello, Caitlin L.
    Usmani, Saad Z.
    Berdeja, Jesus G.
    Omel, Jim
    Thompson, Michael A.
    Shah, Jatin
    Schwartz, J. Sanford
    Hajek, Roman
    Terpos, Evangelos
    Hungria, Vania
    Mateos, Maria-Victoria
    Cook, Gordon
    Leleu, Xavier
    Spencer, Andrew
    Goldschmidt, Hartmut
    Seal, Brian
    Pashos, Chris L.
    Stull, Dawn Marie
    Romanus, Dorothy
    Cacioppo, Roxanne
    Bell, Jill A.
    Yu, Shawn
    Luptakova, Katarina
    Niculescu, Liviu
    Noga, Stephen J.
    Skacel, Tomas
    Chari, Ajai
    BLOOD, 2016, 128 (22)
  • [19] Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187)
    Rifkin, Robert
    Davies, Faith
    Palumbo, Antonio
    Zonder, Jeffrey A.
    Girnius, Saulius
    Costello, Caitlin
    Usmani, Saad
    Berdeja, Jesus
    Omel, Jim
    Thompson, Michael
    Schwartz, J. Sanford
    Hajek, Roman
    Terpos, Evangelos
    Hungria, Vania
    Mateos, Maria-Victoria
    Cook, Gordon
    Leleu, Xavier
    Spencer, Andrew
    Goldschmidt, Hartmut
    Seal, Brian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E79 - E80
  • [20] Thalidomide as rescue of relapses after haematopoietic transplantation in multiple myeloma and as maintenance treatment:: Results of a Spanish multicentre study including 63 patients.
    Alegre, A
    Gil-Fernández, JJ
    Font, P
    Alonso, A
    Sureda, A
    Martínez-Chamorro, C
    Escudero, A
    Sánchez-Godoy, P
    Burgaleta, C
    Casado, LF
    Granda, A
    Aguado, B
    Osorio, S
    Nistal, S
    Mascuñano, R
    Prieto, E
    Fernández-Rañada, JM
    BLOOD, 2002, 100 (11) : 390B - 390B
12345